Louisiana State Employees Retirement System Sells 800 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Louisiana State Employees Retirement System reduced its position in Pediatrix Medical Group, Inc. (NYSE:MD) by 1.9% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 40,900 shares of the company’s stock after selling 800 shares during the quarter. Louisiana State Employees Retirement System’s holdings in Pediatrix Medical Group were worth $474,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. The Manufacturers Life Insurance Company boosted its position in shares of Pediatrix Medical Group by 3.5% in the second quarter. The Manufacturers Life Insurance Company now owns 32,387 shares of the company’s stock valued at $245,000 after acquiring an additional 1,088 shares during the period. ProShare Advisors LLC lifted its position in Pediatrix Medical Group by 7.4% during the first quarter. ProShare Advisors LLC now owns 16,937 shares of the company’s stock valued at $170,000 after purchasing an additional 1,167 shares during the last quarter. Nisa Investment Advisors LLC lifted its position in Pediatrix Medical Group by 47.2% during the second quarter. Nisa Investment Advisors LLC now owns 4,755 shares of the company’s stock valued at $36,000 after purchasing an additional 1,524 shares during the last quarter. SummerHaven Investment Management LLC lifted its position in Pediatrix Medical Group by 3.8% during the second quarter. SummerHaven Investment Management LLC now owns 55,951 shares of the company’s stock valued at $422,000 after purchasing an additional 2,069 shares during the last quarter. Finally, Bank of Montreal Can lifted its position in Pediatrix Medical Group by 0.5% during the second quarter. Bank of Montreal Can now owns 415,110 shares of the company’s stock valued at $3,196,000 after purchasing an additional 2,083 shares during the last quarter. 97.71% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, CFO C Marc Richards sold 17,438 shares of Pediatrix Medical Group stock in a transaction on Monday, August 12th. The shares were sold at an average price of $10.08, for a total value of $175,775.04. Following the transaction, the chief financial officer now directly owns 175,347 shares of the company’s stock, valued at $1,767,497.76. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other Pediatrix Medical Group news, CFO C Marc Richards sold 17,438 shares of the business’s stock in a transaction on Monday, August 12th. The shares were sold at an average price of $10.08, for a total transaction of $175,775.04. Following the transaction, the chief financial officer now directly owns 175,347 shares of the company’s stock, valued at approximately $1,767,497.76. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Laura A. Linynsky sold 7,000 shares of the business’s stock in a transaction on Tuesday, August 27th. The shares were sold at an average price of $11.16, for a total transaction of $78,120.00. Following the transaction, the director now directly owns 30,805 shares in the company, valued at approximately $343,783.80. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 68,100 shares of company stock valued at $701,889 over the last three months. 1.20% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on MD shares. StockNews.com upgraded shares of Pediatrix Medical Group from a “sell” rating to a “hold” rating in a research report on Wednesday, August 7th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Pediatrix Medical Group from $9.00 to $15.00 and gave the company a “hold” rating in a research report on Monday. Truist Financial lifted their target price on shares of Pediatrix Medical Group from $13.00 to $16.00 and gave the company a “hold” rating in a research report on Monday. UBS Group lifted their target price on shares of Pediatrix Medical Group from $10.50 to $16.50 and gave the company a “neutral” rating in a research report on Tuesday. Finally, Mizuho boosted their price objective on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a “neutral” rating in a report on Monday. Five research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $16.10.

Pediatrix Medical Group Trading Up 1.5 %

Shares of MD opened at $15.36 on Wednesday. The firm has a market cap of $1.32 billion, a price-to-earnings ratio of -5.02, a PEG ratio of 2.36 and a beta of 1.55. The company has a debt-to-equity ratio of 0.86, a quick ratio of 1.38 and a current ratio of 1.58. Pediatrix Medical Group, Inc. has a fifty-two week low of $6.62 and a fifty-two week high of $15.52. The firm has a 50 day moving average price of $11.70 and a 200-day moving average price of $9.45.

Pediatrix Medical Group (NYSE:MD) last issued its earnings results on Friday, November 1st. The company reported $0.44 EPS for the quarter, topping the consensus estimate of $0.37 by $0.07. Pediatrix Medical Group had a negative net margin of 12.65% and a positive return on equity of 12.79%. The company had revenue of $511.20 million for the quarter, compared to the consensus estimate of $498.87 million. During the same period in the previous year, the firm earned $0.29 earnings per share. The firm’s revenue for the quarter was up .9% on a year-over-year basis. As a group, equities research analysts forecast that Pediatrix Medical Group, Inc. will post 1.19 earnings per share for the current year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.